BENZTROPINE MESYLATE

BENZTROPINE MESYLATE was reported 2684 times

BENZTROPINE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSTONIC TREMOR 15 0.1705
1 HAEMOGLOBIN URINE 7 0.1628
2 MUSCLE TONE DISORDER 24 0.0769
3 DIABETES WITH HYPEROSMOLARITY 3 0.0517
4 DIABETIC GASTROPATHY 2 0.0500
5 COMPULSIVE LIP BITING 3 0.0288
6 ELECTROCONVULSIVE THERAPY 3 0.0275
7 GRANULOCYTOPENIA 152 0.0267
8 IRON METABOLISM DISORDER 3 0.0252
9 ASPERGER'S DISORDER 2 0.0250
10 EAR INFECTION STAPHYLOCOCCAL 3 0.0246
11 BLOOD CREATINE PHOSPHOKINASE DECREASED 7 0.0213
12 THALASSAEMIA 3 0.0175
13 HYPEROSMOLAR STATE 4 0.0139
14 TOURETTE'S DISORDER 3 0.0132
15 MONOCYTOSIS 8 0.0129
16 EOSINOPHIL COUNT ABNORMAL 9 0.0120
17 PROTRUSION TONGUE 7 0.0120
18 GLOBULINS INCREASED 4 0.0110
19 COLONIC PSEUDO-OBSTRUCTION 3 0.0108
20 BURN INFECTION 2 0.0098
21 AMAUROSIS 8 0.0095
22 ANTIPSYCHOTIC DRUG LEVEL DECREASED 5 0.0094
23 DIABETIC HYPEROSMOLAR COMA 4 0.0093
24 OCULOGYRIC CRISIS 19 0.0088
25 COGWHEEL RIGIDITY 9 0.0086
26 TRISMUS 41 0.0079
27 DERMATOPHYTOSIS 2 0.0070
28 ANTICHOLINERGIC SYNDROME 11 0.0069
29 ENCEPHALITIS AUTOIMMUNE 9 0.0068
30 DELUSION OF GRANDEUR 3 0.0067
31 DIABETIC COMA 18 0.0064
32 C-REACTIVE PROTEIN DECREASED 4 0.0061
33 RESPIRATORY TRACT INFECTION BACTERIAL 3 0.0060
34 CHEST WALL PAIN 2 0.0060
35 ACQUIRED OESOPHAGEAL WEB 2 0.0059
36 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 2 0.0058
37 GAIT SPASTIC 2 0.0058
38 POOR PERSONAL HYGIENE 3 0.0058
39 POSTURING 3 0.0058
40 BREAST HYPERPLASIA 2 0.0057
41 FEEDING TUBE USER 2 0.0055
42 ILEUS PARALYTIC 24 0.0054
43 HEARING DISABILITY 2 0.0051
44 SCHIZOAFFECTIVE DISORDER 9 0.0050
45 MUSCLE CONTRACTURE 10 0.0049
46 ANHIDROSIS 2 0.0049
47 DIABETES MELLITUS NON-INSULIN-DEPENDENT 7 0.0048
48 WHITE BLOOD CELLS URINE POSITIVE 9 0.0048
49 ANTIPSYCHOTIC DRUG LEVEL INCREASED 13 0.0046
50 CATATONIA 24 0.0046
51 DYSPHEMIA 20 0.0046
52 INTESTINAL DILATATION 6 0.0045
53 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
54 DIABETIC COMPLICATION 11 0.0043
55 ECHOCARDIOGRAM ABNORMAL 6 0.0043
56 DIABETIC NEUROPATHY 21 0.0042
57 THERAPEUTIC AGENT TOXICITY 14 0.0042
58 PERSECUTORY DELUSION 10 0.0040
59 NEGATIVISM 3 0.0040
60 PSYCHOTIC SYMPTOM 8 0.0039
61 GRIMACING 3 0.0038
62 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 3 0.0038
63 DRUG LEVEL BELOW THERAPEUTIC 21 0.0038
64 STRESS URINARY INCONTINENCE 4 0.0037
65 CHRONIC HEPATITIS 3 0.0037
66 GLYCOSURIA 5 0.0037
67 BLOOD BICARBONATE DECREASED 7 0.0037
68 DIABETIC NEPHROPATHY 8 0.0036
69 HEAD TITUBATION 5 0.0036
70 SCHIZOPHRENIA 44 0.0036
71 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
72 PSYCHIATRIC DECOMPENSATION 7 0.0036
73 SOLILOQUY 3 0.0035
74 NEPHROGENIC DIABETES INSIPIDUS 4 0.0035
75 DILATATION ATRIAL 4 0.0034
76 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3 0.0034
77 ENDOSCOPY 2 0.0033
78 NEUROLEPTIC MALIGNANT SYNDROME 39 0.0033
79 HYPERLIPIDAEMIA 39 0.0033
80 PARKINSON'S DISEASE 8 0.0031
81 PCO2 DECREASED 3 0.0031
82 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
83 AREFLEXIA 8 0.0030
84 AUTONOMIC NEUROPATHY 3 0.0030
85 CHOREOATHETOSIS 2 0.0029
86 BLOOD PH DECREASED 5 0.0029
87 CHOREA 5 0.0029
88 IMPAIRED SELF-CARE 6 0.0029
89 SYSTOLIC DYSFUNCTION 3 0.0028
90 TYPE 1 DIABETES MELLITUS 17 0.0028
91 BORDERLINE PERSONALITY DISORDER 2 0.0028
92 DIABETIC ULCER 2 0.0028
93 TYPE 2 DIABETES MELLITUS 94 0.0028
94 FOREIGN BODY ASPIRATION 2 0.0028
95 MUTISM 4 0.0028
96 BLUNTED AFFECT 2 0.0027
97 CENTRAL OBESITY 2 0.0027
98 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
99 DYSTONIA 50 0.0026
100 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 2 0.0026
101 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
102 CROUP INFECTIOUS 2 0.0025
103 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
104 LABILE BLOOD PRESSURE 3 0.0025
105 VICTIM OF CRIME 3 0.0024
106 HYPERPARATHYROIDISM 5 0.0024
107 BLOOD UREA DECREASED 3 0.0024
108 SINUS TACHYCARDIA 34 0.0024
109 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
110 NECROTISING COLITIS 3 0.0024
111 TROPONIN T INCREASED 3 0.0024
112 DIABETIC RETINOPATHY 8 0.0024
113 LEFT ATRIAL DILATATION 3 0.0024
114 BLOOD AMYLASE INCREASED 4 0.0023
115 DRUG WITHDRAWAL SYNDROME NEONATAL 34 0.0023
116 PERSONALITY DISORDER 6 0.0023
117 PARKINSONISM 22 0.0023
118 TARDIVE DYSKINESIA 63 0.0022
119 MULTIPLE DRUG OVERDOSE 11 0.0022
120 BLOOD TRIGLYCERIDES INCREASED 39 0.0022
121 FAECALOMA 12 0.0022
122 ACCIDENTAL POISONING 3 0.0022
123 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
124 ESSENTIAL HYPERTENSION 4 0.0022
125 MYOCARDITIS 25 0.0022
126 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
127 TOXIC ENCEPHALOPATHY 11 0.0022
128 LOBAR PNEUMONIA 4 0.0022
129 HYPERPROLACTINAEMIA 14 0.0022
130 LYMPHOCYTE COUNT INCREASED 7 0.0021
131 HALLUCINATION, AUDITORY 34 0.0021
132 BLOOD PROLACTIN INCREASED 10 0.0021
133 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
134 EXCESSIVE EYE BLINKING 3 0.0020
135 DROOLING 14 0.0020
136 POLYDIPSIA 8 0.0020
137 BIPOLAR DISORDER 22 0.0020
138 MUSCLE RIGIDITY 24 0.0020
139 SALIVARY HYPERSECRETION 20 0.0020
140 PSYCHOTIC DISORDER 59 0.0020
141 HOMICIDAL IDEATION 8 0.0020
142 TROPONIN INCREASED 15 0.0020
143 MEAN CELL VOLUME DECREASED 3 0.0019
144 TONGUE BITING 4 0.0019
145 BRUGADA SYNDROME 2 0.0019
146 AKINESIA 4 0.0019
147 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
148 OSTEOSCLEROSIS 3 0.0019
149 OBESITY 30 0.0019
150 TIC 10 0.0018
151 ACARODERMATITIS 2 0.0018
152 COLONIC POLYP 3 0.0018
153 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
154 DEMENTIA WITH LEWY BODIES 2 0.0018
155 ESSENTIAL TREMOR 2 0.0018
156 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
157 NEUTROPHILIA 10 0.0018
158 CEREBRAL ATROPHY 7 0.0018
159 PARANOIA 30 0.0017
160 DELUSION 27 0.0017
161 ACUTE PRERENAL FAILURE 2 0.0017
162 FLAT AFFECT 4 0.0017
163 METABOLIC DISORDER 10 0.0017
164 SEDATION 45 0.0017
165 AKATHISIA 23 0.0017
166 LACUNAR INFARCTION 4 0.0017
167 DRUG LEVEL DECREASED 17 0.0017
168 HALLUCINATIONS, MIXED 7 0.0017
169 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
170 HYPERTENSIVE HEART DISEASE 3 0.0016
171 COMPLETED SUICIDE 132 0.0016
172 MECHANICAL VENTILATION 3 0.0016
173 DIABETES MELLITUS 120 0.0016
174 INTENTIONAL MISUSE 3 0.0016
175 EXTRAPYRAMIDAL DISORDER 39 0.0016
176 SEDATION COMPLICATION 4 0.0016
177 ATROPHY 3 0.0015
178 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
179 SOMNAMBULISM 10 0.0015
180 MITRAL VALVE INCOMPETENCE 17 0.0015
181 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
182 ANION GAP INCREASED 2 0.0015
183 POTENTIATING DRUG INTERACTION 5 0.0015
184 MUCOSAL DRYNESS 3 0.0015
185 LIBIDO INCREASED 3 0.0015
186 CLUMSINESS 4 0.0015
187 CARDIOMYOPATHY 21 0.0014
188 DIABETIC KETOACIDOSIS 34 0.0014
189 MYDRIASIS 18 0.0014
190 DRUG TOXICITY 19 0.0014
191 DYSPHORIA 7 0.0014
192 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
193 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
194 RESPIRATORY RATE INCREASED 12 0.0014
195 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
196 HEAT STROKE 2 0.0013
197 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
198 BRUXISM 7 0.0013
199 FACIAL PARALYSIS 11 0.0013
200 THINKING ABNORMAL 24 0.0013
201 MUSCLE STRAIN 11 0.0013
202 ECONOMIC PROBLEM 19 0.0013
203 DIABETES INSIPIDUS 3 0.0012
204 STUPOR 4 0.0012
205 DISINHIBITION 2 0.0012
206 POSTURE ABNORMAL 4 0.0012
207 DERMAL CYST 3 0.0012
208 MENTAL DISORDER 53 0.0012
209 PEPTIC ULCER 4 0.0012
210 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
211 SUICIDAL BEHAVIOUR 5 0.0012
212 CONGESTIVE CARDIOMYOPATHY 5 0.0012
213 LEUKOPENIA 60 0.0012
214 PREMATURE BABY 36 0.0012
215 VENTRICULAR HYPERTROPHY 3 0.0012
216 SELF-INJURIOUS IDEATION 5 0.0012
217 COLITIS ISCHAEMIC 8 0.0012
218 MYOCLONUS 14 0.0012
219 HEPATOSPLENOMEGALY 3 0.0012
220 PRIAPISM 4 0.0012
221 VIITH NERVE PARALYSIS 4 0.0012
222 BLOOD CHLORIDE INCREASED 2 0.0012
223 HYPERREFLEXIA 4 0.0011
224 CAROTID ARTERY STENOSIS 4 0.0011
225 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
226 PROTEIN TOTAL INCREASED 3 0.0011
227 FEAR OF DISEASE 2 0.0011
228 HAEMORRHAGIC DIATHESIS 4 0.0011
229 RHINITIS ALLERGIC 5 0.0011
230 ALCOHOL POISONING 3 0.0011
231 BREAST SWELLING 3 0.0011
232 ANORGASMIA 3 0.0011
233 MONOCYTE COUNT INCREASED 4 0.0011
234 SCREAMING 7 0.0011
235 HYPERGLYCAEMIA 40 0.0011
236 GALACTORRHOEA 7 0.0011
237 DISORGANISED SPEECH 2 0.0011
238 INCOHERENT 7 0.0011
239 CHRONIC SINUSITIS 4 0.0011
240 DYSKINESIA 43 0.0011
241 HYPERTONIA 6 0.0010
242 POST-TRAUMATIC STRESS DISORDER 7 0.0010
243 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
244 HYPERCHOLESTEROLAEMIA 10 0.0010
245 ORTHOSTATIC HYPOTENSION 18 0.0010
246 BLOOD CHOLESTEROL INCREASED 48 0.0010
247 GASTROINTESTINAL NECROSIS 3 0.0010
248 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
249 NECK INJURY 3 0.0010
250 MENTAL STATUS CHANGES 28 0.0010
251 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
252 METABOLIC ENCEPHALOPATHY 3 0.0010
253 REBOUND ACID HYPERSECRETION 3 0.0010
254 ENURESIS 4 0.0010
255 DYSLIPIDAEMIA 5 0.0010
256 SELF INJURIOUS BEHAVIOUR 3 0.0010
257 DIABETIC FOOT 3 0.0010
258 MASTICATION DISORDER 3 0.0010
259 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
260 GRAND MAL CONVULSION 9 0.0010
261 COMPULSIVE SHOPPING 2 0.0010
262 EJECTION FRACTION DECREASED 15 0.0010
263 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
264 PNEUMONIA ASPIRATION 24 0.0010
265 MAJOR DEPRESSION 7 0.0010
266 RESPIRATORY RATE DECREASED 3 0.0010
267 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
268 ORTHOPNOEA 3 0.0009
269 ANAEMIA MACROCYTIC 2 0.0009
270 VITAMIN D DECREASED 8 0.0009
271 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
272 DELIRIUM 32 0.0009
273 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
274 DEAFNESS NEUROSENSORY 3 0.0009
275 SPINAL OSTEOARTHRITIS 8 0.0009
276 ABNORMAL BEHAVIOUR 36 0.0009
277 DYSARTHRIA 34 0.0009
278 AGGRESSION 45 0.0009
279 RESPIRATORY DEPRESSION 11 0.0009
280 HEART RATE ABNORMAL 5 0.0009
281 TREATMENT NONCOMPLIANCE 49 0.0009
282 IRON DEFICIENCY 4 0.0009
283 CLOSTRIDIAL INFECTION 3 0.0009
284 MOTOR DYSFUNCTION 9 0.0009
285 PERONEAL NERVE PALSY 5 0.0009
286 RESTLESS LEGS SYNDROME 16 0.0009
287 NEUTROPHIL COUNT INCREASED 9 0.0009
288 HAEMOGLOBIN INCREASED 4 0.0009
289 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
290 DIFFICULTY IN WALKING 3 0.0009
291 CERVICAL VERTEBRAL FRACTURE 3 0.0009
292 TACHYPHRENIA 3 0.0009
293 BILIRUBIN CONJUGATED INCREASED 2 0.0009
294 HYPOVOLAEMIA 5 0.0009
295 CRYING 31 0.0009
296 BRADYKINESIA 5 0.0008
297 DRUG LEVEL INCREASED 14 0.0008
298 FIBRIN D DIMER INCREASED 3 0.0008
299 DENTAL OPERATION 2 0.0008
300 AGRANULOCYTOSIS 15 0.0008
301 HALLUCINATION, VISUAL 17 0.0008
302 HYPERNATRAEMIA 4 0.0008
303 HEPATIC ENZYME ABNORMAL 4 0.0008
304 RESTLESSNESS 29 0.0008
305 MANIA 13 0.0008
306 COORDINATION ABNORMAL 11 0.0008
307 SLEEP APNOEA SYNDROME 15 0.0008
308 HYPERTHERMIA 6 0.0008
309 AMMONIA INCREASED 4 0.0008
310 AORTIC ARTERIOSCLEROSIS 2 0.0008
311 BLOOD CHLORIDE DECREASED 2 0.0008
312 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
313 HERNIA REPAIR 2 0.0008
314 TREMOR 127 0.0008
315 ATAXIA 9 0.0008
316 BLOOD ALBUMIN DECREASED 6 0.0008
317 ANGIONEUROTIC OEDEMA 2 0.0007
318 DRUG INTERACTION 119 0.0007
319 BLEPHARITIS 3 0.0007
320 ALCOHOL ABUSE 2 0.0007
321 OVERWEIGHT 4 0.0007
322 BLOOD SODIUM INCREASED 2 0.0007
323 VITAMIN B12 DEFICIENCY 3 0.0007
324 POLYURIA 6 0.0007
325 CLONUS 2 0.0007
326 ASPIRATION 8 0.0007
327 EOSINOPHIL COUNT INCREASED 6 0.0007
328 BLOOD UREA INCREASED 12 0.0007
329 POISONING 9 0.0007
330 HAEMATOCRIT DECREASED 14 0.0007
331 AORTIC VALVE INCOMPETENCE 3 0.0007
332 INTERVERTEBRAL DISC DISORDER 3 0.0007
333 BLOOD URIC ACID INCREASED 4 0.0007
334 TONGUE DISORDER 5 0.0007
335 COMA SCALE ABNORMAL 2 0.0007
336 HYPERTRIGLYCERIDAEMIA 4 0.0007
337 MOUTH HAEMORRHAGE 5 0.0007
338 CONVULSION 39 0.0007
339 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
340 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
341 WHEELCHAIR USER 3 0.0007
342 KETOACIDOSIS 5 0.0007
343 AGITATION 49 0.0007
344 SLEEP DISORDER 47 0.0007
345 CENTRAL VENOUS CATHETERISATION 2 0.0007
346 SUDDEN DEATH 7 0.0007
347 IMPAIRED GASTRIC EMPTYING 9 0.0007
348 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
349 RENAL FAILURE CHRONIC 5 0.0006
350 FIBROSIS 2 0.0006
351 DIASTOLIC DYSFUNCTION 2 0.0006
352 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
353 FAMILY STRESS 2 0.0006
354 CONFUSIONAL STATE 104 0.0006
355 SUSPECTED SUICIDE 3 0.0006
356 LACERATION 6 0.0006
357 TORSADE DE POINTES 5 0.0006
358 BLEPHAROSPASM 4 0.0006
359 DRUG SCREEN POSITIVE 5 0.0006
360 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
361 PULSE ABSENT 3 0.0006
362 TRICUSPID VALVE INCOMPETENCE 5 0.0006
363 MEDICATION RESIDUE PRESENT 3 0.0006
364 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
365 FAECAL INCONTINENCE 3 0.0006
366 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
367 TACHYCARDIA 55 0.0006
368 DIZZINESS POSTURAL 6 0.0006
369 GYNAECOMASTIA 19 0.0006
370 PANCREATITIS 32 0.0006
371 ABDOMINAL TENDERNESS 3 0.0006
372 FLUID INTAKE REDUCED 3 0.0006
373 BRAIN INJURY 6 0.0006
374 HAEMODIALYSIS 5 0.0006
375 FEAR 16 0.0006
376 HYPOTHERMIA 6 0.0006
377 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
378 HEPATIC STEATOSIS 11 0.0006
379 SUICIDAL IDEATION 54 0.0006
380 UNRESPONSIVE TO STIMULI 15 0.0006
381 COGNITIVE DISORDER 27 0.0006
382 DEPRESSION SUICIDAL 2 0.0006
383 CARDIO-RESPIRATORY ARREST 24 0.0006
384 CARDIOMEGALY 7 0.0006
385 INCONTINENCE 6 0.0006
386 RENAL FAILURE ACUTE 24 0.0006
387 FACIAL PARESIS 2 0.0006
388 CHOKING 11 0.0006
389 THERMAL BURN 4 0.0006
390 FRUSTRATION 2 0.0006
391 CAROTID ARTERY OCCLUSION 2 0.0005
392 JAW DISORDER 3 0.0005
393 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
394 INTESTINAL ISCHAEMIA 3 0.0005
395 DENTAL CARIES 6 0.0005
396 ALCOHOL USE 2 0.0005
397 GASTRIC ULCER HAEMORRHAGE 3 0.0005
398 HIATUS HERNIA 7 0.0005
399 VENTRICULAR FIBRILLATION 6 0.0005
400 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
401 BODY TEMPERATURE INCREASED 11 0.0005
402 CARDIAC DYSFUNCTION 2 0.0005
403 ANGER 18 0.0005
404 HEMIPARESIS 9 0.0005
405 ARTERIOSCLEROSIS 5 0.0005
406 BREAST TENDERNESS 4 0.0005
407 MYOCARDIAL ISCHAEMIA 6 0.0005
408 DERMATITIS CONTACT 6 0.0005
409 INCREASED APPETITE 10 0.0005
410 COMMUNICATION DISORDER 2 0.0005
411 BOWEL MOVEMENT IRREGULARITY 4 0.0005
412 CARDIAC ARREST 43 0.0005
413 MUSCLE TWITCHING 12 0.0005
414 ATELECTASIS 5 0.0005
415 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
416 FAECES HARD 2 0.0005
417 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
418 DECREASED INTEREST 3 0.0005
419 DRY MOUTH 41 0.0005
420 HEPATITIS B 3 0.0005
421 LEUKOCYTOSIS 9 0.0005
422 SUICIDE ATTEMPT 30 0.0005
423 END STAGE RENAL DISEASE 9 0.0005
424 DIALYSIS 7 0.0005
425 BLOOD POTASSIUM INCREASED 8 0.0005
426 APPLICATION SITE DISCOLOURATION 2 0.0005
427 WEIGHT INCREASED 110 0.0005
428 ASPHYXIA 4 0.0005
429 PARALYSIS 7 0.0005
430 ABNORMAL FAECES 4 0.0005
431 DRUG ABUSER 3 0.0005
432 PRE-EXISTING CONDITION IMPROVED 3 0.0005
433 DISORIENTATION 19 0.0005
434 SPEECH DISORDER 25 0.0005
435 PERICARDITIS 8 0.0005
436 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
437 BUNDLE BRANCH BLOCK LEFT 2 0.0005
438 HEPATIC PAIN 2 0.0005
439 ALCOHOLISM 2 0.0005
440 DEMENTIA 13 0.0005
441 CARDIAC FLUTTER 3 0.0005
442 HERPES SIMPLEX 3 0.0005
443 PULMONARY CONGESTION 6 0.0005
444 PHARYNGEAL OEDEMA 7 0.0005
445 EMOTIONAL DISORDER 14 0.0005
446 HYPERSOMNIA 13 0.0005
447 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
448 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
449 LETHARGY 26 0.0005
450 HALLUCINATION 34 0.0005
451 ENCEPHALOPATHY 11 0.0004
452 PANCREATITIS ACUTE 10 0.0004
453 HEAD INJURY 14 0.0004
454 TOOTHACHE 8 0.0004
455 NEUTROPHIL COUNT DECREASED 18 0.0004
456 DISEASE RECURRENCE 21 0.0004
457 CONSTIPATION 96 0.0004
458 C-REACTIVE PROTEIN INCREASED 16 0.0004
459 PANIC ATTACK 16 0.0004
460 URINARY INCONTINENCE 13 0.0004
461 EYE MOVEMENT DISORDER 3 0.0004
462 ENCEPHALITIS 3 0.0004
463 HYPOMAGNESAEMIA 6 0.0004
464 ELECTROLYTE IMBALANCE 5 0.0004
465 NEPHROPATHY 4 0.0004
466 ERECTILE DYSFUNCTION 11 0.0004
467 SPLENOMEGALY 5 0.0004
468 BLOOD SODIUM DECREASED 8 0.0004
469 EATING DISORDER 9 0.0004
470 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
471 RED BLOOD CELL COUNT DECREASED 12 0.0004
472 CHOLECYSTITIS 5 0.0004
473 POOR QUALITY SLEEP 9 0.0004
474 AFFECT LABILITY 4 0.0004
475 APHAGIA 2 0.0004
476 HEPATITIS C 5 0.0004
477 PRESCRIBED OVERDOSE 8 0.0004
478 HYPOKINESIA 6 0.0004
479 MENTAL IMPAIRMENT 10 0.0004
480 NO THERAPEUTIC RESPONSE 5 0.0004
481 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
482 BREATH SOUNDS ABNORMAL 2 0.0004
483 HOSPICE CARE 4 0.0004
484 MOVEMENT DISORDER 13 0.0004
485 ABASIA 10 0.0004
486 PHARYNGITIS 5 0.0004
487 CYST 5 0.0004
488 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
489 SUNBURN 3 0.0004
490 ILEUS 5 0.0004
491 ANEURYSM 2 0.0004
492 RESPIRATORY ARREST 11 0.0004
493 CORONARY ARTERY STENOSIS 2 0.0004
494 EMPHYSEMA 4 0.0004
495 OSTEOPENIA 6 0.0004
496 SOMNOLENCE 79 0.0004
497 LIPASE INCREASED 3 0.0004
498 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
499 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
500 DRUG RESISTANCE 10 0.0004
501 CEREBRAL ISCHAEMIA 2 0.0004
502 HYPOALBUMINAEMIA 3 0.0004
503 NICOTINE DEPENDENCE 3 0.0004
504 RHABDOMYOLYSIS 16 0.0004
505 DEPRESSION 87 0.0004
506 AFFECTIVE DISORDER 3 0.0004
507 FURUNCLE 3 0.0004
508 COMA 18 0.0004
509 NEEDLE ISSUE 11 0.0004
510 RETCHING 8 0.0004
511 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
512 PRESYNCOPE 9 0.0004
513 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
514 SKIN LACERATION 4 0.0004
515 TOXICITY TO VARIOUS AGENTS 62 0.0004
516 MUSCULOSKELETAL STIFFNESS 32 0.0004
517 WOUND INFECTION 4 0.0004
518 SEROTONIN SYNDROME 7 0.0004
519 CORONARY ARTERY DISEASE 11 0.0004
520 DYSPHAGIA 34 0.0004
521 DRUG USE DISORDER 3 0.0004
522 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
523 OVERDOSE 76 0.0004
524 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
525 HYPOGLYCAEMIA 17 0.0004
526 CARDIAC VALVE DISEASE 2 0.0003
527 CARDIAC MURMUR 3 0.0003
528 INTESTINAL OBSTRUCTION 13 0.0003
529 LIVER FUNCTION TEST ABNORMAL 10 0.0003
530 HYPERKALAEMIA 12 0.0003
531 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
532 LUNG INFILTRATION 3 0.0003
533 ENERGY INCREASED 2 0.0003
534 BACTERAEMIA 4 0.0003
535 BLOOD CREATININE INCREASED 22 0.0003
536 DRUG ABUSE 28 0.0003
537 INTENTIONAL DRUG MISUSE 7 0.0003
538 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
539 EXOSTOSIS 3 0.0003
540 INCREASED TENDENCY TO BRUISE 3 0.0003
541 HYPOKALAEMIA 15 0.0003
542 SMALL INTESTINAL OBSTRUCTION 4 0.0003
543 MUSCULOSKELETAL CHEST PAIN 5 0.0003
544 AMNESIA 21 0.0003
545 HYPERTENSION 68 0.0003
546 DEFORMITY 3 0.0003
547 VISION BLURRED 44 0.0003
548 NERVOUS SYSTEM DISORDER 10 0.0003
549 MEMORY IMPAIRMENT 44 0.0003
550 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
551 FLANK PAIN 3 0.0003
552 LOSS OF CONSCIOUSNESS 41 0.0003
553 POISONING DELIBERATE 3 0.0003
554 SPUTUM DISCOLOURED 3 0.0003
555 PRODUCT PACKAGING ISSUE 3 0.0003
556 ULCER 5 0.0003
557 HYPOTHYROIDISM 10 0.0003
558 HYPOXIA 11 0.0003
559 INTENTIONAL OVERDOSE 20 0.0003
560 SINUS BRADYCARDIA 3 0.0003
561 AUTOIMMUNE DISORDER 3 0.0003
562 VITAMIN D DEFICIENCY 3 0.0003
563 NODULE 4 0.0003
564 COELIAC DISEASE 3 0.0003
565 ANHEDONIA 8 0.0003
566 LIGAMENT SPRAIN 3 0.0003
567 PERICARDIAL EFFUSION 7 0.0003
568 DEPRESSED MOOD 16 0.0003
569 ANXIETY 86 0.0003
570 HYPOAESTHESIA 45 0.0003
571 INJURY 21 0.0003
572 PRODUCT TASTE ABNORMAL 4 0.0003
573 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
574 TOOTH ABSCESS 3 0.0003
575 TACHYPNOEA 4 0.0003
576 RENAL FAILURE 39 0.0003
577 CIRCULATORY COLLAPSE 5 0.0003
578 MOOD ALTERED 8 0.0003
579 ACUTE HEPATIC FAILURE 4 0.0003
580 TENDERNESS 3 0.0003
581 MEDICATION ERROR 16 0.0003
582 AMENORRHOEA 5 0.0003
583 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
584 PULMONARY EMBOLISM 27 0.0003
585 FULL BLOOD COUNT ABNORMAL 3 0.0003
586 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
587 HAND FRACTURE 2 0.0003
588 INSOMNIA 75 0.0003
589 DIVERTICULUM 2 0.0003
590 CHEST PAIN 52 0.0003
591 BODY HEIGHT DECREASED 3 0.0003
592 FEAR OF INJECTION 2 0.0003
593 ADVERSE DRUG REACTION 25 0.0003
594 CELLULITIS 14 0.0003
595 BALANCE DISORDER 24 0.0003
596 GAIT DISTURBANCE 53 0.0003
597 OESOPHAGITIS 3 0.0003
598 ACUTE MYOCARDIAL INFARCTION 8 0.0003
599 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
600 VISUAL ACUITY REDUCED 9 0.0003
601 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
602 CATARACT 16 0.0003
603 MALNUTRITION 3 0.0003
604 SKIN INFECTION 3 0.0003
605 BLOOD CALCIUM DECREASED 3 0.0003
606 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
607 BONE LOSS 4 0.0003
608 GASTRITIS 7 0.0003
609 HYPOAESTHESIA ORAL 4 0.0003
610 APHASIA 8 0.0003
611 FEELING JITTERY 5 0.0003
612 RESPIRATORY FAILURE 19 0.0003
613 ATRIOVENTRICULAR BLOCK 2 0.0003
614 TENDONITIS 4 0.0003
615 URINARY TRACT INFECTION 44 0.0003
616 VASCULITIS 3 0.0003
617 APNOEA 2 0.0003
618 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
619 HAEMORRHOIDS 5 0.0003
620 SWOLLEN TONGUE 8 0.0003
621 SEXUAL DYSFUNCTION 3 0.0003
622 ARRHYTHMIA 12 0.0003
623 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
624 MOOD SWINGS 8 0.0003
625 ATRIAL FLUTTER 2 0.0003
626 METABOLIC ACIDOSIS 8 0.0002
627 INTENTIONAL SELF-INJURY 5 0.0002
628 NOCTURIA 3 0.0002
629 DECUBITUS ULCER 2 0.0002
630 BRADYCARDIA 13 0.0002
631 DYSURIA 9 0.0002
632 CHOLELITHIASIS 8 0.0002
633 HYPERCALCAEMIA 3 0.0002
634 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
635 TOOTH EXTRACTION 3 0.0002
636 DISTURBANCE IN ATTENTION 13 0.0002
637 VIRAL INFECTION 8 0.0002
638 PULMONARY HYPERTENSION 5 0.0002
639 DEHYDRATION 32 0.0002
640 URINARY RETENTION 8 0.0002
641 OEDEMA 13 0.0002
642 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
643 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
644 HYPOTENSION 47 0.0002
645 SEPSIS 26 0.0002
646 HYPERHIDROSIS 30 0.0002
647 IRRITABILITY 14 0.0002
648 INFUSION SITE PAIN 3 0.0002
649 ANOREXIA 3 0.0002
650 DIPLOPIA 6 0.0002
651 SYNCOPE 23 0.0002
652 PRODUCT DISPENSING ERROR 5 0.0002
653 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
654 SYRINGE ISSUE 4 0.0002
655 NEUTROPENIA 31 0.0002
656 TOOTH INFECTION 3 0.0002
657 MELAENA 5 0.0002
658 CONDITION AGGRAVATED 69 0.0002
659 DYSMENORRHOEA 3 0.0002
660 HAEMOGLOBIN DECREASED 23 0.0002
661 CHROMATURIA 5 0.0002
662 NASAL CONGESTION 13 0.0002
663 BLINDNESS 9 0.0002
664 NEUROPATHY PERIPHERAL 21 0.0002
665 FALL 73 0.0002
666 ACCIDENTAL OVERDOSE 8 0.0002
667 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
668 HIP FRACTURE 7 0.0002
669 BLOOD GLUCOSE ABNORMAL 4 0.0002
670 FEELING COLD 6 0.0002
671 HEPATIC ENCEPHALOPATHY 2 0.0002
672 CARPAL TUNNEL SYNDROME 3 0.0002
673 OXYGEN SATURATION DECREASED 12 0.0002
674 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
675 PHOTOPHOBIA 4 0.0002
676 LYMPHOPENIA 3 0.0002
677 HYPOCALCAEMIA 4 0.0002
678 CHRONIC KIDNEY DISEASE 16 0.0002
679 EYE INFLAMMATION 2 0.0002
680 LOWER LIMB FRACTURE 4 0.0002
681 PARAESTHESIA ORAL 3 0.0002
682 HYPERTHYROIDISM 3 0.0002
683 HERNIA 4 0.0002
684 GASTROENTERITIS 3 0.0002
685 DYSSTASIA 6 0.0002
686 HAEMATURIA 7 0.0002
687 DRUG EFFECT DECREASED 11 0.0002
688 BRONCHITIS 15 0.0002
689 SKIN HAEMORRHAGE 3 0.0002
690 NIGHTMARE 7 0.0002
691 BLADDER DISORDER 2 0.0002
692 PULMONARY MASS 3 0.0002
693 PULMONARY OEDEMA 9 0.0002
694 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
695 RESPIRATORY DISORDER 6 0.0002
696 PRESCRIBED UNDERDOSE 4 0.0002
697 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
698 DEEP VEIN THROMBOSIS 13 0.0002
699 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
700 PLEURAL EFFUSION 12 0.0002
701 PLATELET COUNT DECREASED 21 0.0002
702 EYELID PTOSIS 2 0.0002
703 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
704 PYREXIA 68 0.0002
705 BLOOD PRESSURE DECREASED 13 0.0002
706 OSTEOPOROSIS 8 0.0002
707 RIB FRACTURE 4 0.0002
708 HAEMATOMA 5 0.0002
709 HEART RATE INCREASED 19 0.0002
710 PNEUMONIA 62 0.0002
711 NERVOUSNESS 10 0.0002
712 WITHDRAWAL SYNDROME 8 0.0002
713 PRODUCTIVE COUGH 9 0.0002
714 NIGHT SWEATS 6 0.0002
715 DECREASED ACTIVITY 2 0.0002
716 ATRIAL FIBRILLATION 18 0.0002
717 BACK INJURY 2 0.0002
718 SEPTIC SHOCK 8 0.0002
719 LUNG DISORDER 9 0.0002
720 BLOOD PRESSURE INCREASED 28 0.0002
721 WEIGHT DECREASED 51 0.0002
722 BLOOD GLUCOSE FLUCTUATION 2 0.0002
723 EYE DISORDER 6 0.0002
724 ABNORMAL DREAMS 5 0.0002
725 FACE OEDEMA 3 0.0002
726 MYOCARDIAL INFARCTION 31 0.0002
727 HYPONATRAEMIA 10 0.0002
728 EYE PAIN 10 0.0002
729 HEART RATE IRREGULAR 4 0.0002
730 SCAR 3 0.0002
731 CHOLECYSTECTOMY 2 0.0002
732 ANGINA PECTORIS 5 0.0002
733 PRODUCT USE IN UNAPPROVED INDICATION 43 0.0002
734 EMOTIONAL DISTRESS 21 0.0002
735 UNEVALUABLE EVENT 13 0.0002
736 NEUROTOXICITY 3 0.0002
737 PALPITATIONS 20 0.0002
738 BLOOD GLUCOSE INCREASED 32 0.0002
739 OCULAR HYPERAEMIA 8 0.0002
740 BLOOD IRON DECREASED 2 0.0002
741 DIZZINESS 84 0.0002
742 ASTHMA 19 0.0002
743 GALLBLADDER DISORDER 3 0.0002
744 VOMITING 79 0.0002
745 PRODUCT PRESCRIBING ERROR 4 0.0002
746 THIRST 3 0.0002
747 ACCIDENT 2 0.0002
748 SINUSITIS 17 0.0002
749 CEREBROVASCULAR ACCIDENT 28 0.0002
750 OSTEOARTHRITIS 7 0.0002
751 FIBROMYALGIA 4 0.0002
752 NEURALGIA 4 0.0002
753 RECTAL HAEMORRHAGE 7 0.0002
754 ABDOMINAL DISTENSION 17 0.0002
755 HOSPITALISATION 25 0.0002
756 EYE SWELLING 6 0.0002
757 HAIR COLOUR CHANGES 2 0.0002
758 DYSPNOEA EXERTIONAL 6 0.0002
759 DERMATITIS ALLERGIC 2 0.0002
760 FRACTURE 3 0.0002
761 MUSCULAR WEAKNESS 18 0.0002
762 BRAIN OEDEMA 2 0.0002
763 ABDOMINAL PAIN LOWER 4 0.0002
764 POST PROCEDURAL COMPLICATION 3 0.0002
765 DRUG PRESCRIBING ERROR 3 0.0002
766 CONTUSION 15 0.0002
767 GLAUCOMA 3 0.0002
768 THERAPY NON-RESPONDER 7 0.0002
769 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
770 ABDOMINAL DISCOMFORT 26 0.0002
771 SKIN ULCER 4 0.0002
772 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
773 ASTHENIA 58 0.0002
774 DYSPHONIA 9 0.0002
775 BONE PAIN 9 0.0002
776 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
777 TINNITUS 7 0.0002
778 IMPAIRED HEALING 5 0.0002
779 THROMBOCYTOPENIA 17 0.0002
780 ADVERSE REACTION 2 0.0002
781 RENAL DISORDER 7 0.0002
782 FUNGAL INFECTION 5 0.0001
783 SKIN DISORDER 5 0.0001
784 PREGNANCY 3 0.0001
785 CARDIAC DISORDER 14 0.0001
786 HAIR TEXTURE ABNORMAL 2 0.0001
787 CARDIAC FAILURE CONGESTIVE 12 0.0001
788 INTENTIONAL PRODUCT MISUSE 13 0.0001
789 DRUG WITHDRAWAL SYNDROME 13 0.0001
790 OEDEMA PERIPHERAL 18 0.0001
791 SEIZURE 17 0.0001
792 GINGIVAL BLEEDING 2 0.0001
793 INFLUENZA LIKE ILLNESS 12 0.0001
794 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
795 DEATH 125 0.0001
796 HAEMATOCHEZIA 8 0.0001
797 RESPIRATORY DISTRESS 4 0.0001
798 ROAD TRAFFIC ACCIDENT 6 0.0001
799 PANCYTOPENIA 8 0.0001
800 MOUTH ULCERATION 3 0.0001
801 JOINT INJURY 3 0.0001
802 DRY EYE 7 0.0001
803 HYPOACUSIS 6 0.0001
804 ACCIDENTAL UNDERDOSE 2 0.0001
805 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
806 DEVICE LEAKAGE 6 0.0001
807 DYSPNOEA 78 0.0001
808 FEELING ABNORMAL 33 0.0001
809 APATHY 2 0.0001
810 MIGRAINE 13 0.0001
811 TRANSAMINASES INCREASED 3 0.0001
812 RASH MACULO-PAPULAR 3 0.0001
813 ORAL PAIN 3 0.0001
814 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
815 ILL-DEFINED DISORDER 8 0.0001
816 MUSCLE SPASMS 24 0.0001
817 SHOCK 3 0.0001
818 ANKLE FRACTURE 2 0.0001
819 BACK PAIN 30 0.0001
820 ABDOMINAL PAIN 30 0.0001
821 BASAL CELL CARCINOMA 2 0.0001
822 BONE DENSITY DECREASED 4 0.0001
823 HEADACHE 79 0.0001
824 ANAEMIA 24 0.0001
825 PRODUCT DOSE OMISSION ISSUE 37 0.0001
826 CYSTITIS 4 0.0001
827 PAIN IN EXTREMITY 37 0.0001
828 NAUSEA 99 0.0001
829 HAEMORRHAGE 13 0.0001
830 THROMBOSIS 10 0.0001
831 UNDERDOSE 9 0.0001
832 DEVICE BREAKAGE 5 0.0001
833 BACK DISORDER 2 0.0001
834 PRODUCT DOSE OMISSION 8 0.0001
835 ABDOMINAL PAIN UPPER 25 0.0001
836 STAPHYLOCOCCAL INFECTION 4 0.0001
837 COUGH 34 0.0001
838 OSTEONECROSIS OF JAW 3 0.0001
839 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
840 OROPHARYNGEAL PAIN 11 0.0001
841 HAEMATEMESIS 3 0.0001
842 FATIGUE 92 0.0001
843 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
844 SWELLING 11 0.0001
845 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
846 GASTRIC DISORDER 4 0.0001
847 DECREASED APPETITE 27 0.0001
848 RASH GENERALISED 3 0.0001
849 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
850 RESPIRATORY TRACT INFECTION 3 0.0001
851 DEAFNESS 3 0.0001
852 MUSCULOSKELETAL PAIN 6 0.0001
853 FEELING HOT 7 0.0001
854 EOSINOPHILIA 2 0.0001
855 HEART RATE DECREASED 4 0.0001
856 HEAD DISCOMFORT 2 0.0001
857 DRUG ERUPTION 2 0.0001
858 LIVER DISORDER 5 0.0001
859 EAR INFECTION 3 0.0001
860 DYSPEPSIA 11 0.0001
861 GOUT 2 0.0001
862 PAIN OF SKIN 3 0.0001
863 BLOOD BILIRUBIN INCREASED 3 0.0001
864 GASTROENTERITIS VIRAL 2 0.0001
865 LIMB INJURY 3 0.0001
866 BONE DISORDER 2 0.0001
867 PAIN 67 0.0001
868 DRUG DOSE OMISSION 18 0.0001
869 RASH 47 0.0001
870 DYSGEUSIA 8 0.0001
871 SWELLING FACE 7 0.0001
872 NECK PAIN 6 0.0001
873 BACTERIAL INFECTION 2 0.0001
874 EPISTAXIS 8 0.0001
875 HEPATIC CIRRHOSIS 2 0.0001
876 PAIN IN JAW 3 0.0001
877 FOOT FRACTURE 2 0.0001
878 INTENTIONAL DOSE OMISSION 3 0.0001
879 ACUTE KIDNEY INJURY 16 0.0001
880 PRODUCT SUBSTITUTION ISSUE 6 0.0001
881 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
882 DIARRHOEA 67 0.0001
883 INFECTION 15 0.0001
884 ERUCTATION 2 0.0001
885 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
886 ASCITES 3 0.0001
887 LABORATORY TEST ABNORMAL 3 0.0001
888 WHEEZING 6 0.0001
889 BLOOD PRESSURE ABNORMAL 2 0.0001
890 MALAISE 44 0.0001
891 BLOOD POTASSIUM DECREASED 3 0.0001
892 INFLUENZA 11 0.0001
893 FEEDING DISORDER 2 0.0001
894 VERTIGO 6 0.0001
895 FLUSHING 10 0.0001
896 CHEST DISCOMFORT 10 0.0001
897 LUNG NEOPLASM MALIGNANT 4 0.0001
898 ILLNESS 10 0.0001
899 LIMB DISCOMFORT 3 0.0001
900 FEMUR FRACTURE 3 0.0001
901 POLLAKIURIA 4 0.0001
902 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
903 SKIN EXFOLIATION 8 0.0001
904 CHILLS 11 0.0001
905 OFF LABEL USE 82 0.0001
906 LACTIC ACIDOSIS 3 0.0001
907 VAGINAL HAEMORRHAGE 4 0.0001
908 INCORRECT DOSE ADMINISTERED 21 0.0001
909 JOINT SWELLING 11 0.0001
910 DRUG INEFFECTIVE 120 0.0001
911 EXPIRED PRODUCT ADMINISTERED 3 0.0001
912 THROAT IRRITATION 4 0.0001
913 ARTHRITIS 7 0.0001
914 CARDIAC FAILURE 7 0.0001
915 RASH MACULAR 3 0.0001
916 BURNING SENSATION 6 0.0001
917 SURGERY 5 0.0001
918 ARTHRALGIA 35 0.0001
919 MOBILITY DECREASED 6 0.0001
920 BLOOD GLUCOSE DECREASED 4 0.0001
921 ERYTHEMA 17 0.0001
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
923 THERAPEUTIC RESPONSE DECREASED 5 0.0001
924 CEREBRAL INFARCTION 2 0.0001
925 COLITIS 3 0.0001
926 CARDIOVASCULAR DISORDER 2 0.0001
927 FLUID RETENTION 4 0.0001
928 HEPATITIS 2 0.0001
929 GASTROINTESTINAL DISORDER 7 0.0001
930 THERAPY CESSATION 4 0.0001
931 INFLAMMATION 4 0.0001
932 RHINORRHOEA 5 0.0001
933 PARAESTHESIA 12 0.0001
934 ADVERSE EVENT 7 0.0001
935 NEOPLASM MALIGNANT 5 0.0001
936 TREATMENT FAILURE 6 0.0001
937 ARTHROPATHY 4 0.0001
938 HAEMOPTYSIS 2 0.0001
939 URTICARIA 12 0.0001
940 PRURITUS 27 0.0001
941 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
942 HEPATIC FAILURE 2 0.0001
943 DISCOMFORT 4 0.0001
944 SKIN DISCOLOURATION 3 0.0001
945 DRUG ADMINISTRATION ERROR 2 0.0001
946 NASOPHARYNGITIS 12 0.0001
947 PERIPHERAL SWELLING 10 0.0001
948 HYPERSENSITIVITY 12 0.0001
949 PRODUCT USE ISSUE 12 0.0001
950 RASH ERYTHEMATOUS 3 0.0001
951 COVID-19 11 0.0001
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
953 PRODUCT QUALITY ISSUE 8 0.0001
954 MYALGIA 10 0.0001
955 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
956 ECZEMA 3 0.0001
957 DERMATITIS ATOPIC 3 0.0001
958 VISUAL IMPAIRMENT 7 0.0001
959 CEREBRAL HAEMORRHAGE 2 0.0001
960 RASH PRURITIC 3 0.0001
961 ANAPHYLACTIC REACTION 3 0.0001
962 HEPATIC FUNCTION ABNORMAL 2 0.0001
963 BLISTER 3 0.0001
964 HOT FLUSH 4 0.0001
965 ACNE 4 0.0001
966 EYE IRRITATION 3 0.0001
967 DRUG INTOLERANCE 5 0.0001
968 ALOPECIA 10 0.0001
969 ABORTION SPONTANEOUS 2 0.0000
970 STOMATITIS 3 0.0000
971 INJECTION SITE PAIN 15 0.0000
972 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
973 INJECTION SITE ERYTHEMA 6 0.0000
974 PSORIASIS 6 0.0000
975 FEBRILE NEUTROPENIA 3 0.0000
976 HEPATIC ENZYME INCREASED 3 0.0000
977 INJECTION SITE REACTION 3 0.0000
978 DRUG DEPENDENCE 7 0.0000
979 DEVICE MALFUNCTION 3 0.0000
980 SKIN BURNING SENSATION 3 0.0000
981 INJECTION SITE SWELLING 3 0.0000
982 DRY SKIN 5 0.0000
983 FLATULENCE 2 0.0000
984 HERPES ZOSTER 2 0.0000
985 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
986 DEVICE ISSUE 3 0.0000
987 EXPOSURE DURING PREGNANCY 2 0.0000
988 DISEASE PROGRESSION 3 0.0000
989 NO ADVERSE EVENT 4 0.0000
990 BREAST CANCER 2 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000